**Core Concept**
The question is testing the association between long-term medication use and the development of tremors, a common extrapyramidal side effect. This concept is relevant to the field of pharmacology, specifically the side effect profile of various medications.
**Why the Correct Answer is Right**
The correct answer is associated with the blockade of dopamine receptors in the basal ganglia, leading to an imbalance in the dopaminergic system. This results in the development of extrapyramidal symptoms (EPS), including tremors. The drug works by blocking dopamine D2 receptors, which are involved in motor control and coordination. The blockade of these receptors disrupts the normal function of the basal ganglia, leading to tremors and other EPS.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is not commonly associated with the development of tremors. While it may have other side effects, tremors are not a typical concern with this medication.
* **Option B:** This option is incorrect because it is actually used to treat tremors, rather than cause them. It works by increasing the activity of certain neurotransmitters in the brain that help to control movement.
* **Option C:** This option is incorrect because it is not typically associated with the development of tremors. While it may have other side effects, tremors are not a common concern with this medication.
**Clinical Pearl / High-Yield Fact**
The development of tremors due to long-term medication use is a classic example of an extrapyramidal side effect. Remember the "DOPAmine D2 receptor blockade" mechanism to associate this side effect with dopamine antagonist medications.
**Correct Answer:** C. Haloperidol. Haloperidol is a typical antipsychotic medication that is commonly associated with the development of tremors due to its blockade of dopamine D2 receptors in the basal ganglia.
Free Medical MCQs Β· NEET PG Β· USMLE Β· AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.